Skanditek Industriförvaltning

Skanditek Industriförvaltning AB was a Swedish industrial holding company that specialized in long-term investments in technology-based companies, with a significant focus on the life sciences and healthcare sectors. The company's strategy involved taking active ownership positions in small to medium-sized enterprises to drive growth, internationalization, and operational improvements. Notable life science holdings in its portfolio included Vitrolife, a leader in assisted reproduction technology, and various medical technology firms. In 2010, Skanditek merged with Bure Equity AB, with Bure as the surviving entity, effectively consolidating their investment portfolios and management expertise. The firm was instrumental in scaling Nordic biotech and medtech companies before its integration into Bure.